Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression X Zhang, S Zhang, X Yang, J Yang, Q Zhou, L Yin, S An, J Lin, S Chen, ... Molecular cancer 9, 1-12, 2010 | 481 | 2010 |
Caspase-11–mediated endothelial pyroptosis underlies endotoxemia-induced lung injury KT Cheng, S Xiong, Z Ye, Z Hong, A Di, KM Tsang, X Gao, S An, M Mittal, ... The Journal of clinical investigation 127 (11), 4124-4135, 2017 | 361 | 2017 |
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Q Lan, CA Hsiung, K Matsuo, YC Hong, A Seow, Z Wang, HD Hosgood III, ... Nature genetics 44 (12), 1330-1335, 2012 | 327 | 2012 |
Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer Q Zhou, XC Zhang, ZH Chen, XL Yin, JJ Yang, CR Xu, HH Yan, HJ Chen, ... J Clin Oncol 29 (24), 3316-3321, 2011 | 285 | 2011 |
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status SJ An, ZH Chen, J Su, XC Zhang, WZ Zhong, JJ Yang, Q Zhou, XN Yang, ... PloS one 7 (6), e40109, 2012 | 212 | 2012 |
EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas ZY Chen, WZ Zhong, XC Zhang, J Su, XN Yang, ZH Chen, JJ Yang, ... The oncologist 17 (7), 978-985, 2012 | 208 | 2012 |
Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types JN Sampson, WA Wheeler, M Yeager, O Panagiotou, Z Wang, SI Berndt, ... Journal of the National Cancer Institute 107 (12), djv279, 2015 | 181 | 2015 |
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals J Zhu, W Zhong, G Zhang, R Li, X Zhang, A Guo, Y Zhang, S An, TS Mok, ... Cancer letters 265 (2), 307-317, 2008 | 148 | 2008 |
miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer X Tan, J Peng, Y Fu, S An, K Rezaei, S Tabbara, CB Teal, Y Man, ... Breast cancer research 16, 1-14, 2014 | 131 | 2014 |
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma P Zhang, J Miska, C Lee-Chang, A Rashidi, WK Panek, S An, M Zannikou, ... Proceedings of the National Academy of Sciences 116 (47), 23714-23723, 2019 | 117 | 2019 |
G enetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer … MJ Machiela, CA Hsiung, XO Shu, WJ Seow, Z Wang, K Matsuo, YC Hong, ... International journal of cancer 137 (2), 311-319, 2015 | 100 | 2015 |
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapy J Guan, W Zhong, S An, J Yang, J Su, Z Chen, H Yan, Z Chen, Z Huang, ... Annals of surgical oncology 20, 1381-1388, 2013 | 98 | 2013 |
In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines H Cheng, SJ An, XC Zhang, S Dong, YF Zhang, ZH Chen, HJ Chen, ... Cancer chemotherapy and pharmacology 67, 637-646, 2011 | 86 | 2011 |
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings … WJ Seow, K Matsuo, CA Hsiung, K Shiraishi, M Song, HN Kim, MP Wong, ... Human molecular genetics 26 (2), 454-465, 2017 | 76 | 2017 |
Blockade of hedgehog signaling synergistically increases sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer cell lines XY Bai, XC Zhang, SQ Yang, SJ An, ZH Chen, J Su, Z Xie, LY Gou, YL Wu PloS one 11 (3), e0149370, 2016 | 76 | 2016 |
The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with … Q Nie, Z Wang, G Zhang, S An, J Lin, A Guo, R Li, B Gan, Y Huang, ... European Journal of Pharmacology 570 (1-3), 175-181, 2007 | 63 | 2007 |
Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women Z Wang, WJ Seow, K Shiraishi, CA Hsiung, K Matsuo, J Liu, K Chen, ... Human molecular genetics 25 (3), 620-629, 2016 | 61 | 2016 |
Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients R Li, SJ An, ZH Chen, GC Zhang, JQ Zhu, Q Nie, Z Xie, AL Guo, TS Mok, ... Human pathology 39 (12), 1792-1801, 2008 | 56 | 2008 |
Molecular Toxicology Progress of Carcinogenic Polycyclic Aromatic Hydrocarbons Research AN Shejuan, C Jiakun, C Xuemin FOREIGN MEDICAL SCIENCES(SECTION HYGIENE) 32 (1), 10-13, 2005 | 50* | 2005 |
Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma MT Wang, G Chen, SJ An, ZH Chen, ZM Huang, P Xiao, XS Ben, Z Xie, ... Diseases of the Esophagus 25 (7), 664-670, 2012 | 48 | 2012 |